They're close to the results seen in the STEP 1 trial, where participants lost 15% of their starting weight on average with injectable semaglutide
"Patients Taking Experimental Obesity Drug Lost More Than 50 Pounds, Maker Claims"
Collaborating closely with a healthcare provider is essential to determine the optimal dosage regimen for your unique needs
Members access detailed escalation schedules tailored to their specific vial concentrations, troubleshooting resources for side effect management, and evidence-based guidance on when to escalate, hold, or reduce their dose
After initiation and dose increases, patients should be observed carefully for signs and symptoms of pancreatitis (including persistent severe abdominal pain, sometimes radiating to the back and which may or may not be accompanied by vomiting)
Using the medication correctly and consistently is key to achieving and maintaining a healthy body weight